Following Court Order, HHS Officially Delays Rebate Ban Rule

By John Wilkerson / February 19, 2021 at 2:14 PM
HHS on Thursday (Feb. 18) officially delayed for one year its ban on drug rebates after being ordered to do so by a federal judge . The rule would hurt pharmacy benefit managers and the insurers that hire them to negotiate drug prices, and it would benefit drug makers that have been paying increasingly larger rebates over the past several years. The rebate rule, titled “Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.